Hypertension News
Hypertension. Read about the latest medical research on reducing high blood pressure, treatment options for hypertension and more.
-
Scientists find a hidden cause of high blood pressure that routine tests can miss
A wearable device has revealed nighttime hormone surges that may expose a frequently missed cause of high blood pressure. The discovery could help explain why primary aldosteronism often escapes standard blood tests and point toward a more accurate way to diagnose it. -
Who really needs a heart calcium scan?
A 10-year study of more than 6,000 adults found that popular coronary calcium scans may add little to standard heart disease risk estimates for many people. But for patients with borderline or intermediate risk, the scans could make a meaningful difference by revealing who is actually more likely to develop heart disease. -
Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings. -
Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways
Scientists have uncovered why two seemingly opposite ways of targeting the same brain receptor can both promote weight loss. In mice, activating the GIP receptor in the brainstem reduced appetite, while blocking it in the hypothalamus removed a kind of “brake” on fullness signals. The discovery helps explain why very different obesity drugs can achieve similar results and suggests that carefully combining GIP-targeting treatments with GLP-1 drugs like those related to Wegovy and Ozempic could produce stronger effects. -
Misfolded insulin may be quietly driving diabetes
Researchers found that insulin-producing cells depend on a team of helper proteins to keep insulin production on track. When one key partner was missing, damaged proteins built up and the cells made less insulin. Strengthening this system could offer a new way to protect the pancreas as diabetes progresses. -
Ozempic and Mounjaro linked to a surprising hair loss risk
A large study suggests that GLP-1 drugs including Ozempic and Mounjaro may slightly increase the risk of hair loss in people with type 2 diabetes. Compared with two other common classes of diabetes medications, GLP-1 users had a significantly higher rate of alopecia, though the absolute risk was still low. The hair loss was mainly non-scarring, which means it may be reversible. -
The mysterious hum heard around the world may finally have an explanation
The mysterious sound known as The Hum has been reported worldwide for decades, yet its source often remains impossible to find. Researchers tested whether people who hear it have exceptional low-frequency hearing or measurable sounds produced inside their ears, but neither explanation fit most participants. The strongest possibility is that many cases involve low-frequency tinnitus, even though the sound seems completely external. -
Scientists detect hidden skin damage before it becomes visible
Scientists have discovered a hidden warning sign of skin damage that appears before collagen fibers visibly thin, break, or lose their connections. Using advanced light-based techniques, the team found that collagen’s carefully organized molecular “handedness” can collapse even while the tissue still appears structurally intact and contains the same amount of collagen. This suggests that skin may begin deteriorating at a much deeper level long before conventional imaging can detect a problem.